ID   G6PE_HUMAN              Reviewed;         791 AA.
AC   O95479; Q4TT33; Q66I35; Q68DT3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   10-MAY-2017, entry version 155.
DE   RecName: Full=GDH/6PGL endoplasmic bifunctional protein;
DE   Includes:
DE     RecName: Full=Glucose 1-dehydrogenase;
DE              EC=1.1.1.47;
DE     AltName: Full=Hexose-6-phosphate dehydrogenase;
DE   Includes:
DE     RecName: Full=6-phosphogluconolactonase;
DE              Short=6PGL;
DE              EC=3.1.1.31;
DE   Flags: Precursor;
GN   Name=H6PD; Synonyms=GDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=10349511; DOI=10.1006/bcmd.1999.0224;
RA   Mason P.J., Stevens D., Diez A., Knight S.W., Scopes D.A.,
RA   Vulliamy T.J.;
RT   "Human hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
RT   encoded at 1p36: coding sequence and expression.";
RL   Blood Cells Mol. Dis. 25:30-36(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ALA-151 AND
RP   GLN-453.
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-453.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-157 AND ASN-282.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   VARIANT CRD GLN-453, AND CHARACTERIZATION OF VARIANT CRD GLN-453.
RX   PubMed=12858176; DOI=10.1038/ng1214;
RA   Draper N., Walker E.A., Bujalska I.J., Tomlinson J.W., Chalder S.M.,
RA   Arlt W., Lavery G.G., Bedendo O., Ray D.W., Laing I., Malunowicz E.,
RA   White P.C., Hewison M., Mason P.J., Connell J.M., Shackleton C.H.L.,
RA   Stewart P.M.;
RT   "Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase
RT   type 1 and hexose-6-phosphate dehydrogenase interact to cause
RT   cortisone reductase deficiency.";
RL   Nat. Genet. 34:434-439(2003).
RN   [9]
RP   VARIANT CRD LEU-146, AND CHARACTERIZATION OF VARIANT CRD LEU-146.
RX   PubMed=23132696; DOI=10.1530/EJE-12-0628;
RA   Lavery G.G., Idkowiak J., Sherlock M., Bujalska I., Ride J.P.,
RA   Saqib K., Hartmann M.F., Hughes B., Wudy S.A., De Schepper J.,
RA   Arlt W., Krone N., Shackleton C.H., Walker E.A., Stewart P.M.;
RT   "Novel H6PDH mutations in two girls with premature adrenarche:
RT   'apparent' and 'true' CRD can be differentiated by urinary steroid
RT   profiling.";
RL   Eur. J. Endocrinol. 168:K19-K26(2013).
CC   -!- FUNCTION: Oxidizes glucose-6-phosphate and glucose, as well as
CC       other hexose-6-phosphates.
CC   -!- CATALYTIC ACTIVITY: D-glucose + NAD(P)(+) = D-glucono-1,5-lactone
CC       + NAD(P)H. {ECO:0000255|PROSITE-ProRule:PRU10005}.
CC   -!- CATALYTIC ACTIVITY: D-glucose 6-phosphate + NAD(P)(+) = D-glucono-
CC       1,5-lactone 6-phosphate + NAD(P)H.
CC   -!- CATALYTIC ACTIVITY: 6-phospho-D-glucono-1,5-lactone + H(2)O = 6-
CC       phospho-D-gluconate.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
CC       Note=Microsomes, endoplasmic reticulum lumen.
CC   -!- TISSUE SPECIFICITY: Present in most tissues examined, strongest in
CC       liver.
CC   -!- DISEASE: Cortisone reductase deficiency (CRD) [MIM:604931]: In
CC       CRD, activation of cortisone to cortisol does not occur, resulting
CC       in adrenocorticotropin-mediated androgen excess and a phenotype
CC       resembling polycystic ovary syndrome (PCOS).
CC       {ECO:0000269|PubMed:12858176, ECO:0000269|PubMed:23132696}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the glucose-6-
CC       phosphate dehydrogenase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the
CC       glucosamine/galactosamine-6-phosphate isomerase family. 6-
CC       phosphogluconolactonase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH18137.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=H6PD";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ012590; CAA10071.1; -; mRNA.
DR   EMBL; CR749282; CAH18137.1; ALT_INIT; mRNA.
DR   EMBL; Z98044; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC081559; AAH81559.1; -; mRNA.
DR   CCDS; CCDS101.1; -.
DR   RefSeq; NP_004276.2; NM_004285.3.
DR   RefSeq; XP_006711115.1; XM_006711052.3.
DR   RefSeq; XP_016858354.1; XM_017002865.1.
DR   UniGene; Hs.463511; -.
DR   ProteinModelPortal; O95479; -.
DR   SMR; O95479; -.
DR   BioGrid; 114933; 3.
DR   IntAct; O95479; 1.
DR   STRING; 9606.ENSP00000366620; -.
DR   BindingDB; O95479; -.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; O95479; -.
DR   PhosphoSitePlus; O95479; -.
DR   BioMuta; H6PD; -.
DR   EPD; O95479; -.
DR   MaxQB; O95479; -.
DR   PaxDb; O95479; -.
DR   PeptideAtlas; O95479; -.
DR   PRIDE; O95479; -.
DR   Ensembl; ENST00000377403; ENSP00000366620; ENSG00000049239.
DR   GeneID; 9563; -.
DR   KEGG; hsa:9563; -.
DR   UCSC; uc001apt.4; human.
DR   CTD; 9563; -.
DR   DisGeNET; 9563; -.
DR   GeneCards; H6PD; -.
DR   H-InvDB; HIX0000104; -.
DR   HGNC; HGNC:4795; H6PD.
DR   HPA; HPA004824; -.
DR   HPA; HPA005440; -.
DR   MalaCards; H6PD; -.
DR   MIM; 138090; gene.
DR   MIM; 604931; phenotype.
DR   neXtProt; NX_O95479; -.
DR   OpenTargets; ENSG00000049239; -.
DR   Orphanet; 168588; Hyperandrogenism due to cortisone reductase deficiency.
DR   PharmGKB; PA29170; -.
DR   eggNOG; KOG0563; Eukaryota.
DR   eggNOG; KOG3147; Eukaryota.
DR   eggNOG; COG0363; LUCA.
DR   eggNOG; COG0364; LUCA.
DR   GeneTree; ENSGT00530000063435; -.
DR   HOGENOM; HOG000231077; -.
DR   HOVERGEN; HBG005780; -.
DR   InParanoid; O95479; -.
DR   KO; K13937; -.
DR   PhylomeDB; O95479; -.
DR   TreeFam; TF354247; -.
DR   BioCyc; MetaCyc:HS00614-MONOMER; -.
DR   SABIO-RK; O95479; -.
DR   ChiTaRS; H6PD; human.
DR   GeneWiki; H6PD; -.
DR   GenomeRNAi; 9563; -.
DR   PRO; PR:O95479; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000049239; -.
DR   CleanEx; HS_H6PD; -.
DR   ExpressionAtlas; O95479; baseline and differential.
DR   Genevisible; O95479; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0017057; F:6-phosphogluconolactonase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047936; F:glucose 1-dehydrogenase [NAD(P)] activity; IEA:UniProtKB-EC.
DR   GO; GO:0004345; F:glucose-6-phosphate dehydrogenase activity; TAS:ProtInc.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006098; P:pentose-phosphate shunt; IEA:InterPro.
DR   CDD; cd01400; 6PGL; 1.
DR   InterPro; IPR005900; 6-phosphogluconolactonase_DevB.
DR   InterPro; IPR001282; G6P_DH.
DR   InterPro; IPR019796; G6P_DH_AS.
DR   InterPro; IPR022675; G6P_DH_C.
DR   InterPro; IPR022674; G6P_DH_NAD-bd.
DR   InterPro; IPR006148; Glc/Gal-6P_isomerase.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   PANTHER; PTHR23429; PTHR23429; 1.
DR   Pfam; PF02781; G6PD_C; 1.
DR   Pfam; PF00479; G6PD_N; 1.
DR   Pfam; PF01182; Glucosamine_iso; 1.
DR   PRINTS; PR00079; G6PDHDRGNASE.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR01198; pgl; 1.
DR   PROSITE; PS00069; G6P_DEHYDROGENASE; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glucose metabolism; Glycoprotein; Hydrolase;
KW   Multifunctional enzyme; NAD; NADP; Oxidoreductase; Polymorphism;
KW   Pyrrolidone carboxylic acid; Reference proteome; Signal.
FT   SIGNAL        1     19       {ECO:0000250}.
FT   CHAIN        20    791       GDH/6PGL endoplasmic bifunctional
FT                                protein.
FT                                /FTId=PRO_0000010442.
FT   REGION       20    526       Glucose 1-dehydrogenase.
FT   REGION      527    540       Linker.
FT   REGION      541    791       6-phosphogluconolactonase.
FT   ACT_SITE    267    267       Proton acceptor. {ECO:0000250}.
FT   BINDING      34     34       NADP. {ECO:0000250}.
FT   BINDING      66     66       NADP. {ECO:0000250}.
FT   BINDING     204    204       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10005}.
FT   BINDING     208    208       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10005}.
FT   MOD_RES      20     20       Pyrrolidone carboxylic acid.
FT                                {ECO:0000250|UniProtKB:P56201}.
FT   MOD_RES     208    208       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8CFX1}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    282    282       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    683    683       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     146    146       P -> L (in CRD; results in reduced
FT                                enzymatic activity).
FT                                {ECO:0000269|PubMed:23132696}.
FT                                /FTId=VAR_069193.
FT   VARIANT     151    151       D -> A (in dbSNP:rs34603401).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_049117.
FT   VARIANT     218    218       R -> Q (in dbSNP:rs35525021).
FT                                /FTId=VAR_049118.
FT   VARIANT     453    453       R -> Q (in CRD; less than 50% of activity
FT                                than wild-type; dbSNP:rs6688832).
FT                                {ECO:0000269|PubMed:12858176,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_026487.
FT   VARIANT     484    484       N -> D (in dbSNP:rs35404275).
FT                                /FTId=VAR_049119.
FT   VARIANT     554    554       P -> L (in dbSNP:rs17368528).
FT                                /FTId=VAR_049120.
FT   CONFLICT    339    339       A -> G (in Ref. 1; CAA10071).
FT                                {ECO:0000305}.
SQ   SEQUENCE   791 AA;  88893 MW;  01E179BE00C87C79 CRC64;
     MWNMLIVAMC LALLGCLQAQ ELQGHVSIIL LGATGDLAKK YLWQGLFQLY LDEAGRGHSF
     SFHGAALTAP KQGQELMAKA LESLSCPKDM APSHCAEHKD QFLQLSQYRQ LKTAEDYQAL
     NKDIEAQLQH AGLREAGRIF YFSVPPFAYE DIARNINSSC RPGPGAWLRV VLEKPFGHDH
     FSAQQLATEL GTFFQEEEMY RVDHYLGKQA VAQILPFRDQ NRKALDGLWN RHHVERVEII
     MKETVDAEGR TSFYEEYGVI RDVLQNHLTE VLTLVAMELP HNVSSAEAVL RHKLQVFQAL
     RGLQRGSAVV GQYQSYSEQV RRELQKPDSF HSLTPTFAAV LVHIDNLRWE GVPFILMSGK
     ALDERVGYAR ILFKNQACCV QSEKHWAAAQ SQCLPRQLVF HIGHGDLGSP AVLVSRNLFR
     PSLPSSWKEM EGPPGLRLFG SPLSDYYAYS PVRERDAHSV LLSHIFHGRK NFFITTENLL
     ASWNFWTPLL ESLAHKAPRL YPGGAENGRL LDFEFSSGRL FFSQQQPEQL VPGPGPAPMP
     SDFQVLRAKY RESPLVSAWS EELISKLAND IEATAVRAVR RFGQFHLALS GGSSPVALFQ
     QLATAHYGFP WAHTHLWLVD ERCVPLSDPE SNFQGLQAHL LQHVRIPYYN IHPMPVHLQQ
     RLCAEEDQGA QIYAREISAL VANSSFDLVL LGMGADGHTA SLFPQSPTGL DGEQLVVLTT
     SPSQPHRRMS LSLPLINRAK KVAVLVMGRM KREITTLVSR VGHEPKKWPI SGVLPHSGQL
     VWYMDYDAFL G
//
